跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,375 条关于
“double-expressor lymphoma”
全部
65,375
临床试验
59,620
药物
264
机构
29
资讯
5,462
去年
Brukinsa-RCHOP Combination Shows Promise in Double-Expressor Lymphoma Treatment with 89.6% Response Rate
10个月前
Sequential PD-1 Inhibitors Show Promise as Consolidation Therapy Following CD19 CAR-T Treatment in Relapsed NHL
3年前
European Commission Approves Axicabtagene Ciloleucel for Second-Line DLBCL and HGBL
去年
CCL2/CCR2 Pathway Identified as Key Driver of Aggression in Double-Expressor DLBCL
2年前
Enfortumab Vedotin Plus Pembrolizumab Doubles Survival in Advanced Bladder Cancer
去年
BioCardia Completes Phase III Trial of CardiAMP Cell Therapy for Ischemic Heart Failure
2年前
Ropeginterferon Alfa-2b Evaluated in Phase 3 Trial for Early/Lower-Risk Myelofibrosis
3年前
Anbalcabtagene Autoleucel Shows 84% Response Rate in Relapsed/Refractory Large B-Cell Lymphoma
去年
Double-Dose Dolutegravir Shows Promise in Reducing HIV Viral Reservoir
10个月前
Ajinomoto Partners with Forge Biologics to Double Gene Therapy Manufacturing Productivity
第 1 页,共 547 页
上一页
下一页